A novel AI analyzes whole histopathology images to predict cancer subtypes, TP53 mutations, and survival outcomes across 32 cancers.
Key Details
- 1The AI model uses routine H&E-stained whole slide images to simultaneously predict cancer subtype, TP53 mutation status, and survival outcomes.
- 2Model was trained on over 11,000 tumor cases from the Pan-Cancer Atlas with both imaging and molecular/genetic data.
- 3Achieved AUROC of 0.766 for TP53 mutation detection across 32 tumor types on an independent validation set (1,729 slides).
- 4Utilizes weakly supervised learning to identify meaningful patterns from slide-level labels without requiring detailed region annotations.
- 5Designed to be used as a complementary tool for screening/triage and decision-support, not as a replacement for molecular testing.
Why It Matters
This approach demonstrates how AI can link routine imaging with molecular diagnostics—potentially increasing testing accessibility, improving triage, and enhancing decision support in pathology workflows, especially in resource-constrained settings.
Source
EurekAlert
Related News
•EurekAlert
TRUECAM AI Framework Boosts Reliability in Cancer Pathology Imaging
PolyU researchers introduce the TRUECAM AI framework to enhance the trustworthiness of pathology AI for cancer diagnosis.
•EurekAlert
Deep Learning Shows Superior Sensitivity in Sinus Disease CT Changes
Automated deep learning achieves greater sensitivity in detecting treatment-related changes in chronic sinus disease on CT scans than standard visual scoring.
•EurekAlert
Mayo Clinic's AI Advances Ultrasound Detection of Heart Obstruction
Mayo Clinic researchers have developed an AI model that detects heart obstructions from routine ultrasound, potentially improving early identification of at-risk patients.